Sort
30,917 grants matching “tumor microenvironment”
Understanding How Microstructure and Interstitial Fluid Pressure Gradient Modulate Cell Invasion in a Bioprinted Tumor-On-a-Chip
$575,000Amir K Miri · New Jersey Institute Of Technology · · FY2024 · ENG
Targeting adrenergic stress pathways to Increase tumor sensitivity to radiation and promote development of an anti-tumor immune response
$574,981Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2019 · CA
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$574,981Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2023 · CA
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
$574,964Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2020 · HL
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer
$574,961Quynh-Thu X Le · Stanford University · R01 · FY2021 · DE
Penn Quantitative MRI Resource for Pancreatic Cancer
$574,949Rong Zhou · University Of Pennsylvania · U24 · FY2022 · CA
Project 2: Diabetes, RAGE/DIAPH1 and Hind Limb Ischemia
$574,907Ann Marie Schmidt · New York University School Of Medicine · P01 · FY2021 · HL
High Content Representation and Association of 3D Cell Culture Models
$574,907Bahram A. Parvin · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2013 · CA
Mechanisms of Murine Turmor Eradication by Immunotherapy
$574,748Philip D Greenberg · University Of Washington · R01 · FY2017 · CA
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$574,360David Akhavan · University Of Kansas Medical Center · R01 · FY2025 · CA
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
$574,360David Akhavan · University Of Kansas Medical Center · R01 · FY2023 · CA
Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy
$574,292Lily Yang · Emory University · U01 · FY2015 · CA
A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
$574,272Xiaomin Fan · Avantgen, Inc. · R44 · FY2025 · CA
Predicting Prostate Cancer Aggressiveness
$574,247Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2012 · CA
Arrayed Microfluidic Device for Reconstituted Tissue Assays
$574,233Steven A Hayes · Bellbrook Labs, Llc · R44 · FY2007 · CA
Mechanisms of breast cancer associated with obesity
$574,175Charlotte Kuperwasser · Tufts University Boston · R01 · FY2013 · CA
Development of Physiologic Tissue Models to Assess Tumor Explant Response to Immune Checkpoint Blockade
$574,170Roger D. Kamm · Massachusetts Institute Of Technology · U01 · FY2017 · CA
Targeting Stromal Influences on BCKA Addiction in PDAC Tumors
$574,113Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$574,084Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · CA
Regulation and Function of Stromal Macropinocytosis in Pancreatic Ductal Adenocarcinoma
$574,084Cosimo Commisso · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Hexokinase 2 and cancer therapy
$574,013Nissim Hay · University Of Illinois At Chicago · R01 · FY2025 · CA
Pathophysiologic Consequences of Neurotrophin Activation of Trk in Neuroblastoma
$573,937Carol Thiele-Galetto · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
A platform to functionally sort and analyze tumor cells within combinatorial metastatic micorenvironments
$573,913David Kevin Wood · University Of Minnesota · R01 · FY2022 · CA
Single Cell Methods for Bioeffector Discovery and Analysis
$573,883Brian O Bachmann · Vanderbilt University · R01 · FY2020 · CA
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$573,873Kenneth J. Pienta · University Of Michigan At Ann Arbor · U01 · FY2010 · CA